Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:328-330
doi: 10.1161/CIRCRESAHA.108.182238
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, G. K.
Right arrow Articles by Bender, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, G. K.
Right arrow Articles by Bender, J. R.
Related Collections
Right arrowRelated Article
(Circulation Research. 2008;103:328.)
© 2008 American Heart Association, Inc.


Editorials

Rac, PAK, and eNOS ACTion

Gautham K. Rao, Jeffrey R. Bender

From the Sections of Cardiovascular Medicine and Immunobiology, Raymond and Beverly Sackler Foundation, and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Conn.

Correspondence to Jeffrey R. Bender, MD, The Anlyan Center S469, 300 Cedar St, New Haven, CT 06510. E-mail jeffrey.bender@yale.edu



See related article, pages 360–368


Key Words: Rac1 • eNOS • endothelium • angiogenesis


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Rac1 is a member of the Rho family of GTPases, which includes Rho, Rac, and cdc42 subfamilies.1,2 On activation by guanine nucleotide exchange factors, the Rho family GTPases exchange a GDP molecule for a GTP and act as molecular switches to transduce signals in response to various extracellular stimuli.2 Apart from their characteristic role in the regulation of cytoskeletal rearrangement and cell adhesion, the Rho family proteins have been found to regulate polarization, endocytosis, intracellular trafficking, cell cycle progression, differentiation, and gene transcription.1 Rho family GTPases play a role in endothelial permeability, polarization, leukocyte adhesion, and production of reactive oxygen species, including the superoxide anion (OFormula 2).3–5 More specifically, activation of endothelial cells with growth factors such as vascular endothelial growth factor or by fluid shear stress has been shown to activate Rac1, which, in turn, promotes cytoskeletal rearrangement and changes in cell motility.6,7 Endothelial activation by growth factors or shear stress also results in the activation of NADPH oxidases (NOXs) and endothelial NO synthase (eNOS), which are responsible for the production of OFormula 2 and NO, respectively.8–10 Because the modulation of endothelial NOXs by Rac1 has been well demonstrated,11–13 it is believed that Rac1 influences endothelial function, as measured by NO bioavailability, by enhancing the production of OFormula 2 and not by direct modulation of eNOS. This assumes mutually exclusive mechanisms for the production of OFormula 2 and NO and that a decreased bioavailability of NO on Rac1 activation is a result of OFormula 2-dependent peroxynitrite production.8,14 Any association with or direct . . . [Full Text of this Article]


Related Article:

Regulation of Endothelial Nitric Oxide Synthase and Postnatal Angiogenesis by Rac1
Naoki Sawada, Salvatore Salomone, Hyung-Hwan Kim, David J. Kwiatkowski, and James K. Liao
Circ. Res. 2008 103: 360-368. [Abstract] [Full Text] [PDF]